Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China · Delayed Price · Currency is CNY 33.78
-0.27 (-0.79%)
Feb 13, 2026, 3:00 PM CST
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 10.68 billion as of February 13, 2026. Its market cap has decreased by -2.89% in one year.
Market Cap
10.68B
Enterprise Value
12.20B
Revenue
1.90B
Ranking
n/a
PE Ratio
20.96
Stock Price
33.78
Market Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 10.68B, a decrease of -35.38%. That is a compound annual growth rate of -8.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 10.68B | -10.40% |
| Dec 31, 2025 | 11.92B | 4.42% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
| May 20, 2021 | 16.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HitGen | 11.92B |
| Chengdu Easton Biopharmaceuticals | 11.77B |
| Vcanbio Cell & Gene Engineering Corp., | 11.74B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 11.35B |
| Aurisco Pharmaceutical | 10.95B |
| Liaoning Chengda Biotechnology | 10.65B |
| Chongqing Genrix Biopharmaceutical | 10.53B |
| Chengzhi | 10.45B |